p¼0.543 (UTI)], patient satisfaction [p¼0. 913, 0.863, 0.913, 0.552], pain rates [p¼0.389, 0.389, 0.637, 0.160], and IQOL scores [p¼0.522]. Regarding the surgical procedure, duration of perioperative antibiotics prophylaxis significantly effected long-term pain rates (p¼0.036), patient satisfaction rates (p¼0.007), and correlated significantly with reduced IQOL scores (R¼-0.531, p<0.001). Surgical approach, catheter size and indwelling time, and intraoperative complications had no significant effect on the analyzed endpoints.
INTRODUCTION AND OBJECTIVES: Although frequently prescribed, the role of postoperative oral antibiotics in preventing artificial urinary sphincter (AUS) explant is unknown. We aimed to determine whether postoperative oral antibiotics are associated with decreased risk of explantation following AUS.
METHODS: We queried the MarketScan database (a large national, prospectively-maintained database of private insurance claims) to identify male patients undergoing AUS placement between 2003 and 2014. The primary endpoint was AUS explantation, determined by CPT codes. Multivariate regression analysis assessed for independent predictors of explantation, including peri-and postoperative antibiotic administration. RESULTS: We identified 3594 patients who underwent AUS placement at mean age 68.1 years (AE0.15). 141 of 3594 (3.9%) patients underwent AUS explant at a median 41.5 days (IQR 20-61) after index surgery. Rates of explant stratified by risk factors are detailed in Table 1 . On multivariate regression analysis, controlling for age and multiple previously described comorbid risk factors, we identified age >75 years, diagnosis of diabetes, and Charlson comorbidity index >1 to be independently associated with AUS explant (Table 1) . The 2300 patients (64%) who received postoperative oral antibiotics did not experience any reduction in explant rate relative to those not receiving postoperative oral antibiotics (3.91% vs 3.95%, adjusted OR 1.01, 95% CI 0.71-1.45). Explant rates were similar among the approximately one-quarter of patients for whom perioperative IV antibiotic data were available, with no difference in explant rates observed for the 64% of patients receiving an antibiotic regimen consistent with AUA guidelines (4.5% vs 4.3%, p¼0.89).
CONCLUSIONS: Postoperative oral antibiotics are prescribed to nearly two-thirds of patients but are not associated with reduced risk of explant following AUS placement. Given the risks to individuals associated with use of antibiotics and increasing bacterial resistance, routine use of oral antibiotics after AUS should be reconsidered. 
INTRODUCTION AND OBJECTIVES:
The artificial urinary sphincter (AUS) AMS 800 has proven to be very effective in treatment of stress urinary incontinence. However, surgeon practice patterns vary when the device does not provide the desired degree of dryness. A common approach utilized is to add additional fluid to the pressure regulating balloon (PRB). The goal of this study was to evaluate changes in pressure with the addition of fluid to the PRB. METHODS: Ex vivo pressure studies were conducted on Boston Scientific AMS 800 PRBs rated 51-60, 61-70 and 71-80 cmH2O in a controlled laboratory setting using the Laborie Aquarius TT urodynamics system. After calibration of the equipment and appropriate cycling of the balloons in a standardized technique similar to that performed in the operating room setting, PRBs were initially filled to 10mL using 0.9% normal saline and opening pressures were obtained. We reported mean and standard deviation. Balloons were inflated up to 35 mL and pressure-volume data sets were acquired for each device.
RESULTS: The mean opening pressures at 10 mL fill volumes of the 51-60, 61-70, and 71-80 cmH2O PRBs were 51.0AE4.8, 65.1AE7.8, and 78.9AE3.9 cmH2O, respectively. The pressure-volume curves appeared similar for all PRBs and rose to maximum pressures of 67.0AE4.0, 87.3AE5.1 and 105.7AE2.4 cmH2O at fill volumes of 16, 17 and 16 mL, respectively for each type of PRB. The addition of any more volume to the balloons did not result in any additional increase in pressure up to a fill volume of 35 mL (see Figure 1) . Following data collection, we continue filling the balloons to a volume of 500 mL. Even at these supra-physiologic volumes, pressures remained stable and only started slowly increasing to 100, 105 and 110 cmH2O respectively at 1 liter.
CONCLUSIONS: The AUS PRB is a very compliant device and adding more fluid to an in situ AUS PRB does not increase the pressure of the system. Although our study does not account for in vivo behavior within a possible capsule formation, we discourage this surgeon practice and recommend adopting a different corrective method for persistent urinary incontinence. 
Although the AUS is still considered the gold standard for treatment of men with moderate or severe stress urinary incontinence (SUI), the transobturator male sling is a viable alternative for milder cases. We hypothesized that increasing selectivity of male sling patients improves clinical outcomes of the AdVance male sling procedure. We reviewed our 8 year experience with AdVance sling cases to determine the association of patient clinical characteristics and clinical outcomes over time at our institution.
METHODS: We conducted a retrospective review of patients who underwent placement of the AdVance male sling for PPI between 2008 -2015. Of those 231 patients identified, 166 had complete data for review including demographics and important pre-operative patient characteristics [pads per day (PPD), radiation history, time from cancer treatment, smoking, diabetes, hypertension, BMI, and physical demonstration of urine during Standing Cough Test (SCT) evaluationdetermined as favorable (Grade 0-2) or unfavorable (Grade 3-4)]. We measured success post-operatively based on progression to further anti-incontinence surgery or lack of SUI improvement.
RESULTS: Among 148 men who underwent AdVance sling placement with complete data available, 41(28%) failed during the mean follow up of 2 years. Median age and delay from prostate cancer treatment was similar between groups. Advance sling failure was associated with an increased PPD (median 2.5 [IQR 2-3.5] vs 1.5 [IQR 1-3]) (p¼0.01). Those with unfavorable findings on SCT had a 50% failure rate, while those with favorable findings had a 25% failure rate (p¼0.05). Patients with a history of XRT failed 63% of the time vs 23% who failed without radiation (p<0.0001). On multivariable analysis, each one pad increase in PPD (OR 1.46, 95%CI 1.10-1.94, p¼ 0.008), prior XRT (OR 6.59, 95%CI 2.36-19.56, p¼0.0003), and unfavorable SCT (OR 4.04, 95%CI 1.11-15.59, p¼0.03) were independently associated with sling failure. The addition of the SCT to the model significantly increased the ability to detect sling failure (AUC 0.77 vs 0.73).
CONCLUSIONS: Identifying patients with ideal characteristics preoperatively is associated with improved outcomes following AdVance male sling placement. Patients with a history of radiation and men found to have heavy leakage during standing cough test were at a significantly higher risk for failure of the sling. A model of prior XRT, PPD, and SCT evaluation had an improved selectivity for sling success.
Source of Funding: none

MP46-16 POST-OPERATIVE TRANSOBTURATOR MALE SLING URINARY RETENTION RESOLVES SPONTANEOUSLY WITH TIME AND MAY BE ASSOCIATED WITH HIGHER LONG-TERM SUCCESS
Divya Ajay*, Bryce Allio, Ramiro Madden-Fuentes, Andrew Peterson, Durham, NC INTRODUCTION AND OBJECTIVES: Post-operative urinary retention (POUR) has been reported in 3-21% of patients undergoing a male transobturator sling (TOS) for post-prostatectomy urinary incontinence (PPUI). Our objective was to examine the natural history of POUR in men undergoing TOS, and review the treatment options and resolution rates to propose an algorithm for management.
METHODS: We reviewed men undergoing a TOS at our institution from 2006 to 2012. Demographic data, post-operative complications and outcomes were extracted by chart review. Post-operative TOS success was defined as the use of 0 or 1 security pads/day, negative stress test on exam or pad weight less than 8 g/day. POUR was defined as patient reported inability to void requiring urological intervention. Ttest, fisher 0 s exact test, cox regression model and Kaplan-Meier survival analysis were performed.
RESULTS: 290 men with PPSUI that underwent a TOS were identified. POUR was reported in 11.7% (34/290). 33 of these 34 patients had a radical prostatectomy and 1 had a radical cystoprostatectomy with an orthotopic neobladder. POUR was associated with a lower average BMI (25AE 2 versus 28AE 3, p<0.01). Age, diabetes, pelvic radiation, a prior or concurrent bladder neck contracture had no correlation with POUR. We identified no urodynamic parameters that could distinguish patients that develop POUR during preoperative evaluation. 67.6% (23/34) patients were taught and performed temporary clean intermittent catheterization (CIC), 29% (10/34) had a temporary indwelling foley placed. All patients resolved spontaneously with 85% (29/33) lasting 1-7 days and 12% (4/33) for 7-30 days. Figure 1 shows survival estimates of TOS failure in men who experienced shortterm POUR versus those who did not (p¼0.04). Those with POUR had better long term outcomes with a hazard ratio of 0.47 (95%CI 0.2-1.0). None had permanent retention nor required surgical intervention such a sling release.
CONCLUSIONS: We feel that this information is valuable in that all cases resolved spontaneously thus allowing us to avoid surgical intervention in these cases. We propose the following algorithm outlined in Figure 2 for the management of POUR. Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e625
